key: cord-0933340-wl4p6rms
authors: Egorova, Anna; Bogner, Elke; Novoselova, Elena; Zorn, Kimberley M.; Ekins, Sean; Makarov, Vadim
title: Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review)
date: 2020-11-12
journal: Eur J Med Chem
DOI: 10.1016/j.ejmech.2020.113014
sha: 70b5cd8d3dc9aa9ba07f4012265d1bf0f73a9b9f
doc_id: 933340
cord_uid: wl4p6rms

Viruses are obligate intracellular parasites and have evolved to enter the host cell. To gain access they come into contact with the host cell through an initial adhesion, and some viruses from different genus may use heparan sulfate proteoglycans for it. The successful inhibition of this early event of the infection by synthetic molecules has always been an attractive target for medicinal chemists. Numerous reports have yielded insights into the function of compounds based on the dispirotripiperazine scaffold. Analysis suggests that this is a structural requirement for inhibiting the interactions between viruses and cell-surface heparan sulfate proteoglycans, thus preventing virus entry and replication. This review summarizes our current knowledge about the early history of development, synthesis, structure-activity relationships and antiviral evaluation of dispirotripiperazine-based compounds and where they are going in the future.

(epigallocatechin gallate), aminoquinolines (surfen), and finally, dispirotripiperazines (DSTP27) seem to be attractive for further development as antivirals with a mechanism of action aimed at inhibiting HSGAG [13] .

Dispirotripiperazines belong to the class of dispiro compounds, i.e. tricyclic molecules with two shared atoms (or "spiro atoms"), and they can be conditionally divided into three types depending on their component composition: a) a dispiro system with three six-membered cyclespiperazines -or "6-6-6", b) a dispiro system with two six-membered cycles and one sevenmembered cycle -homopiperazine -or "6-7-6" and c) a dispiro system with one six-membered cycle and two seven-membered cycles or "7-6-6" (a dispiro system with three seven-membered cycles is highly unstable and thus not shown) (Fig. 1) . A unique feature of dispirotripiperazines is the presence of two quaternary positively charged nitrogen atoms in the structure, which are possibly responsible for electrostatic interactions with negatively charged HSGAGs. Initially, dispirotripiperazines were investigated as antitumor drugs (prospidine, spirobromine) [14, 15] ; however, in the following studies, it was found that these compounds also have good antiviral activity [16] . In this review, we provide an overall review of the status of dispirotripiperazine derivatives and their evolution as broad-spectrum antivirals. General information on the role of HS glycosaminoglycans in the entry of different viruses is described in the first section. The second section introduces the history of dispirotripiperazine chemistry, the discovery of the first antitumor drugs based on dispirotripiperazine pharmacophore, and the recent studies in this area. Finally, in the third section, we provide an overview of current knowledge on the development of J o u r n a l P r e -p r o o f 6 dispirotripiperazines with a heparan-binding mechanism, an emphasis on their antiviral activity and future potential.

Infection of enveloped and non-enveloped viruses occurs in several steps. The viral replication cycle is divided into attachment, penetration, uncoating, nucleic acid synthesis, translation of viral proteins, virion assembly and release. The first stage of viral replicationattachment -implies that the virus comes into close contact with the host cell, and this is a prerequisite for the following receptor binding. Viral adsorption is mediated by the interactions between viral envelope proteins and receptors or attachment factors of host cells. These surface molecules include ligand-binding receptors, for example, ion channels, enzymes, glycoconjugates (glycoproteins and glycolipids) and proteoglycans [17] . It is important to emphasize that many viruses may use multiple attachment factors and receptors in parallel or sequential interactions with them, or use different receptors or co-opt cellular processes to penetrate into different cell types [17] .

It is well known that one of the cell-surface molecules, HS proteoglycans (HSPGs), are the major component of the extracellular matrix and are located on the plasma membrane of all mammalian cells [18] . Each HSPG consists of one or more HS glycosaminoglycan chain, long linear polysaccharides (40-300 sugar residues) containing repeating disaccharide residues covalently bound to the central core protein via a tetrasaccharide bridge ( Fig. 2A ) [19] .

Cell-surface HSPGs can be divided into two main groups depending on the nature of the core protein (Fig. 2B) . Syndecans are transmembrane proteins structurally composed of an Nterminal signal sequence, an ectodomain and a short C-terminal cytosolic tail. They are anchored to the cell surface by a hydrophobic transmembrane domain [20] . Glypicans are not transmembrane glycoproteins but are extracellularly bound to the plasma membrane via a C-terminal lipid moiety, HSPGs interact with a wide range of proteins (at least 300), such as growth factors, cytokines, chemokines and coagulation factors, leading to involvement in many important normal biological processes. The physiological function of HS binding proteins varies from cell adhesion, migration and differentiation, blood coagulation to wound healing, immune response, synapse organization and so on [13, 19] . At the same time, HSPGs are involved in causing cancer and neurodegenerative disorders [13] .

In addition, HSPGs also provide binding sites for many human bacterial and viral pathogens [23, 24] . It was found that herpes simplex virus (HSV), human papillomavirus (HPV), human immunodeficiency virus (HIV), and hepatitis virus all use HSGAG as a receptor or attachment factor for entry into the host cell [25] [26] [27] [28] [29] . Initial contact with host cells via HSGAG is also required for some echo-and rhinoviruses, yellow fever virus, some coronaviruses, cytomegalovirus, footand-mouth disease virus and filoviruses [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] . However, different biological studies of the role of HSPGs in the entry of such viruses as respiratory syncytial virus (RSV) and Zika virus indicate different outcomes, and more clear evidence of their role is needed [40] [41] [42] .

HSGAG can be classed as an anionic molecule due to the presence of sulfate and carboxyl groups and it is widely used as a binding site for many viruses from different classes which also makes HSGAG a potential target for the prevention of viral infection and pathogenicity. It is reasonable to hypothesize that cationic antiviral agents will effectively block the electrostatic interactions between HSGAG and viral envelope glycoproteins by temporary competitive binding to the negatively charged HS. In this context, we now consider the research and development of potential antivirals in the class of cationic small molecules, such as dispirotripiperazines. 9 researchers (only one compound from this chemical class was previously known [43] ) [44, 45] . It [44, 45] .

In the following studies, it was found that spirazidine had a wide spectrum of anti-cancer activity with relatively low toxicity. This compound was highly effective in the treatment of malignant neoplasms of the larynx or nasopharynx and cancer of the lungs or bladder. Moreover, it was noted that there was no negative effect on hematopoiesis [46] . However, spirazidine has some shortcomings such as low chemical stability, which was an obstacle to industrial development. Using 3, 

Clinical studies of prospidine demonstrated efficacy in the treatment of patients with laryngeal, or lung, or bladder cancers [14] . In addition, this drug has also been studied in the therapy of rheumatoid arthritis [49] [50] [51] as it inhibits proinflammatory cytokine production [49] .

Spirobromine, unlike prospidine, had a different spectrum of antitumor action as it is more active towards sarcoma 45 and 536 in rats and sarcoma 180 in mice [52] . Spirobromine possesses antileukemic activity, whereas prospidine did not influence the development of the leukemia process in mice [52] . It was established that the chemotherapeutic index of spirobromine on Jensen sarcoma was two-fold greater than that of prospidine. Moreover, spirobromine was less toxic than prospidine (LD 50 = 1924 mg/kg vs. LD 50 = 100 mg/kg) after a single intraperitoneal injection in J o u r n a l P r e -p r o o f mice [52] . Prospidine and spirobromine are still used by Russian physicians in oncology practice as cytostatic antitumor chemotherapeutic drugs with an alkylating mode of action while little is known of their use in the west.

Prospidine and spirobromine may be considered bis(β-chloroethyl)amine derivatives. While prospidine has γ-chloro-β-hydroxypropyl groups on the terminal nitrogen atoms, which are required for its alkylating ability, spirobromine contains β-bromopropionyl residues at the same site, and this structural distinction influences their different spectrum of antitumor activity [53] . The tricyclic system also contributes to the activity, whereas the compounds with an "open" central ring of the system are inactive [54] . However, the role of such a positively charged system on antitumor capacity is unclear, Dorokhova et al. proposed that the dispiro system serves as a carrier for the functional groups [54] . Pol'shakov et al. found that the guanine residues may be the main binding sites for prospidine to DNA, in contrast to spirobromine, which does not bind to them [55] .

Moreover, Geodakyan and Chernov suggested that the effect of prospidine on intracellular processes in tumor cells may be mediated by the effect of the drug on the permeability of their plasma membrane [56, 57] . But these studies were carried out many years ago and have not yet been confirmed with modern methods.

Further investigations to identify spirobromine analogues with similar antitumor activity failed as all of the synthesized compounds were found to be less active than spirobromine [58] . The functionalization of 12b resulted in the key compounds 17a-c.

Among the synthesized derivatives, only the dispirotripiperazines 13a with the chloroethylcarbamoyl side chain and 17a with the β-bromopropanoyl side chain inhibited Jensen's sarcoma, sarcoma M-1 and melanoma B-16, whereas several other compounds 13b-e, 14a,b and 17b,c did not show antitumor activity. However, the antitumor activity of 13a and 17a did not exceed the activity of spirobromine and prospidine, thus further studies were discontinued [59] .

In 2009, Liu et al. [60] described compound 19 (Scheme 4) which was designed based on the structure of cyclophosphamide, a common alkylating agent in anticancer therapy, and J o u r n a l P r e -p r o o f 13 spirobromine with the key dispirotripiperazine moiety. This compound was synthesized by a onestep synthesis from the reaction of freshly prepared 2-chloro-1,3,2-oxazaphosphinane 2-oxide 18 with previously known 3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane dichloride 4 in the presence of NaHCO 3 (Scheme 4). Unfortunately, no further results of biological evaluation were reported, and it is possible to suppose that the data were unsatisfactory, as further studies focused only on the synthesis of cyclophosphamide spiropiperazinium salts [61] .

3. The present of dispirotripiperazines: progress as compounds with HS-binding mechanism of action

In order to study a wide spectrum of biological activity of spirobromine, Levkovskaya et al. 

It was found that both spirobromine 8 and its analogue 24 with the insertion of NH-fragment in the side chain of the molecule inhibited the replication of the HSV-1 L 2 strain at equal concentrations, but at the same time, spirobromine 8 was more active towards the HSV-2 T r strain.

A brief summary of the initial studies of the SAR based on the structure of spirobromine is shown in Fig. 4 . were significantly less active than compounds without substituents in this position (the exception is a compound with a methyl group). The incorporation of a furoxan ring to pyrimidine leads to a decrease in the overall activity of the molecules, but one such compound, DSTP27 25 (Fig. 5B) , was chosen for further detailed studies. Another promising derivative from this chemical library is compound PDSTP 26 (Fig. 5B) with a double dispirotripiperazine moiety linked to nitropyrimidine. Western blot analysis, the authors suggested that the inhibitory effect was associated with the block of early steps of the viral replication cycle, but not attachment. It was also observed that DSTP27 is metabolically unstable due to its ability to release nitric oxide [68] . Taken However, PDSTP has no significant effect on a herpetic encephalitis mouse model when used as monotherapy, only in combination therapy with acyclovir is it effective, which suggests that a combination of the antiviral agents with different modes of action might resolve the problem of emergent resistance [69] . At the same time, PDSTP was found to be more effective compared to acyclovir in a guinea pig model of genital herpes, reducing symptom intensity scores, mean duration of illness, and viral titers [70] .

Target-based drug discovery was used to propose several structurally related PDSTP derivatives, containing different combinations of piperazine/homopiperazine cycles 27d-f, 28a-f, 29a,b,d,e (Fig. 7A ) which were synthesized and tested for activity against HSV-1 [71] . During SAR studies, it was additionally confirmed that only the 2-methyl-5-nitropyrimidine moiety is associated with high anti-HSV-1 activity of dispirotripiperazines: as compounds 28b, 29b were the most active The antiviral activity of the lead molecule 29b towards HPV16 pseudovirions was evaluated using a neutralization assay (Fig. 8) . It was found that the compound reduces the infectivity of There are some key structural requirements of dispirotripiperazine-core compounds for their antiviral activity, such as:

1. As with anticancer activity, the presence of two quaternary positively charged nitrogen atoms in the dispirotripiperazine system is critical for inhibitory activity against viruses. In the case of antivirals, charged molecules are likely to interact electrostatically with the HSPGs on the cell surface;

2. The nitropyrimidine moiety was found to strongly contribute to the antiviral effect of the molecules, which suggests that dispirotripiperazines bind to HSPGs not only through electrostatic interactions, but also through hydrogen-bonding of the nitro group and two nitrogen atoms of the heterocycle with HSPG's functional groups, but this statement needs to be clarified;

3. Dispirotripiperazines exhibit antiviral activity regardless of the piperazine/homopiperazine combination in their structure;

Finally, in this section, we summarize the main representatives of the dispirotripiperazine class and their in vitro antiviral activity observed to date in the Table 1 . it is also worth mentioning one more dispirotripiperazine derivative namely adhesamine. In contrast, this molecule acts as an agonist of the heparan sulfate proteoglycans, boosting cell adhesion and growth, so the compound may potentially be used as a cell-attaching reagent for cell therapy [72] . Adhesamine 36, chemically known as 3,12-bis[6-chloro-5-formyl-2-(methylsulfanyl)-4-pyrimidinyl]-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane ditrifluoroacetate (Fig. 9) , was found during screening of chemical library by Yamazoe et al. [72] . Cell biology assays showed that adhesamine binds to selective cell-surface glycosaminoglycans, especially heparan sulfate, increasing cell adhesion and growth. Additionally, it was found that this small synthetic molecule induces normal cell adhesion similar to fibronectin, a general cell adhesion protein. SiRMS method has also been previously described with advantages including consideration of the different physical chemical properties of atoms and good interpretability of models [76] .

It was established that the antiherpetic activity and cytotoxicity of molecules predominantly depend on electrostatic factors (38% or 50%, respectively), hydrophobicity (25% and 34%, respectively), atom nature (19% and 16%, respectively), dispersion (10%) and H-bonding (8%) also have some effect on the activity (Fig. 10 ). The importance of data curation and validation for such computational models is paramount and the reader is referred to earlier articles on the best practices for such modeling and the J o u r n a l P r e -p r o o f discussion of the benefits of making such models available for others [77, 78] . We have now analyzed the broad set of dispirotriperazines with HSV-1 inhibition data at a threshold of IC 50 < 10 µM as active (N=28) using the Assay Central ® machine learning software as previously described [79] [80] [81] [82] [83] . A high-quality structure-activity dataset was first created (i.e. structures are de-salted and neutralized, finite activities merged) then a Bayesian algorithm was applied utilizing extendedconnectivity fingerprints (ECFP6) as molecular descriptors [79, 80] . Due to the limited data availability for these compounds, we set a binary threshold so that an IC 50 < 10 µM was considered active (N = 28), and those without IC 50 data at the time were considered inactive. The model can be used to predict new molecules from chemical structure alone ( Figure 11A ). We also curated 70

HSV-1 inhibitors from the ChEMBL database (target id CHEMBL613200) to build a separate model with a calculated threshold of 10.42 µM ( Figure 11B ). This model was then used to score 39 dispirotriperazines with IC 50 values at this same threshold, with reasonable performance ( Figure   11C ). Finally a model was built which combined the 70 ChEMBL compounds and the 39 compounds with IC 50 data herein to total 109 molecules, resulting in a calculated threshold of 10.42 µM ( Figure 11D ); this model expands the chemical space to more specifically target the dispirotriperazines and was utilized to score prospective molecules and prioritize synthesis in this series. These efforts demonstrate that public HSV-1 data can to some degree rank the HSV-1 activity for the dispirotriperazines and that a combination of datasets may aid us in predicting this activity for future analogues.

J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f

As illustrated by the recent SARS-CoV-2 outbreak, viruses continue to represent a great threat to humanity. Broad spectrum vaccines or synthetic drugs against a large number of viruses are still not available to tackle this virus at the time of writing. There are different strategies for the development of broader spectrum antivirals, and the search for small molecules, which could prevent the initial interactions between the virus and the host cell, is certainly worth pursuing for the future. Viral adsorption is therefore the earliest infectious event in the viral life cycle and is one of the most promising target for the development of new antiviral drugs.

As we have described, in order to gain access to the cell interior, viruses attach to the cellsurface receptor and many viruses from different classes have evolved to use cell-surface HSPGs as either direct receptors, co-receptors or attachment factors for penetration into the cell. However, the contradictory data of the role of heparan sulfate in virus entry for several viruses has been reported (e.g. RSV and Zika virus [40] [41] [42] ), thus more biological investigations are required.

Several different strategies are currently being studied to target HSPGs including their inhibition by dispirotripiperazine-based compounds [13] . According to in vitro studies, a representative of the class of dispirotripiperazines, DSTP-27, binds to heparan sulfate proteoglycans [57] . It may be assumed that this binding occurs through electrostatic interactions between the negatively charged heparin/heparan and the positively charged dispirotripiperazine fragment of the molecules and also through hydrogen-bonding of nitro-pyrimidines with functional groups of HSPG. Based on data available to date on the various SARs with different viruses, greater insights of the key structural features of dispirotripiperazine-based compounds for antiviral activity and HS binding were provided. Compounds from this class, PDSTP and compound 29b, were previously found to be active against strains of herpesvirus and human immunodeficiency virus and may be further investigated against other viruses that use HSPGs.

Thus, the synthesis of compounds in this class of cationic dispirotripiperazines could be continued to provide further more in-depth views on the SARs of binding to HSGAGs in order to find the most active broad spectrum antiviral agent amongst them with enhanced stability, solubility etc. We will also need to pay special attention to drug safety issues, since HSPGs are involved in many different physiological processes [13, 19] . With a growing database of information for this class of compounds it may open up the potential for further computational analyses. It is certainly worth considering that the antiviral activity of dispirotripiperazines may not be limited to targeting HSPGs alone. Moreover, it is worth mentioning the potential of dispirotripiperazines not only as antivirals, but also as agents in other pathophysiological processes associated with the negatively charged HS involvement, such as antibacterials, anticancer drugs, antiparkinsonian agents, and others.

World Health Organization, Coronavirus disease (COVID-2019) situation reports

World Health Organization, Deaths from Democratic Republic of the Congo measles outbreak top 6000

Zika Travel Information

World Health Organization, Ebola situation report

World Health Organization, Ebola in the Democratic Republic of the Congo

Déjà vu: Stimulating open drug discovery for SARS-CoV-2

Learning from history: do not flatten the curve of antiviral research!

Antiviral drugs and antiviral drug resistance

Cytomegalovirus resistance testing: pitfalls and problems for the clinician

Virus entry by endocytosis

Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias? Viruses

Surface Proteoglycans as Mediators in Bacterial Pathogens Infections

Targeting heparin and heparan sulfate protein interactions

Prospidine and several other derivatives of spiropolypiperazines

Spirobromin: synthesis and biological properties, in: Antitumor Preparations (Collections of academic works of All-Union Scientific Research Chemical-Pharmaceutical Institute)

Synthesis, cytotoxicity and antiviral activity of N,N'-bis-5-nitropyrimidyl derivatives of dispirotripiperazine

Virus Entry and Uncoating

Heparan sulphate proteoglycans fine-tune mammalian physiology

Heparan sulfate proteoglycans

Heparan sulfate proteoglycans: a sugar code for vertebrate development? Development

Glycosaminoglycans and infection

Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry

Human papillomavirus infection requires cell surface heparan sulfate

Human immunodeficiency virus and heparan sulfate: From attachment to entry inhibition

Role of glycosaminoglycans for binding and infection of hepatitis B virus

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection

Echoviruses bind heparan sulfate at the cell surface

Studies of Echovirus 5 interactions with the cell surface: Heparan sulfate mediates attachment to the host cell

Human Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment

Entry of a heparan sulphate-binding HRV8 variant strictly depends on dynamin but not on clathrin, caveolin, and flotillin

Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus

Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells

Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans

A role for 3-Osulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells

Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis

Filoviruses utilize glycosaminoglycans for their attachment to target cells

Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide

Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures

Role of heparan sulfate in the Zika virus entry, replication, and cell death

Sur les pipérazines N-monoarylées et leurs dérivés

Synthesis of dispiro-tripiperazine derivatives with cancerolytic properties

Haloalkylamines and their transformation products. I. About interaction of bis(β-chloroethyl)amine with α-oxides

Haloalkylamines and their transformation products. III. Spirazidine, prospidin, and some other N′,N″-dispirotripiperazinium derivatives

Haloalkylamines and their transformation products. II. N′,N′′-dispirotripiperazinium derivatives

Haloakylamines and their transformation products. IV. Synthesis and antiblastic activity of some piperazine derivatives

The new basic agent prospidin in the therapy of rheumatoid arthritis. An evaluation of the clinical effectiveness and the mechanism of action of prospidin

Prospidine versus methotrexate pulse in highly active rheumatoid arthritis: a controlled 6-month clinical trial

Pulse therapy with prospidin and methotrexate: comparative efficacy in rheumatoid arthritis (12-month controlled study)

New antitumor agent -Spirobromin

Cycle-dependent effects of antitumor drugs of the dispirotripiperazine series: Spirobromine and prospidin

Haloakylamines and their transformation products

Interaction of the antitumor drugs phospidine and spirobromine with nucleotides

About the role of plasma membrane in the mechanism of antitumor action of prospidine

The role of the cell surface in the mechanism of the action of antineoplastic drugs (literature survey)

Dependence of the antitumor activity of spirobromin analogs on their structure

heptadecane Derivatives

Synthesis of a novel class of cyclophosphamide bis-spiropiperazinium salts

A novel class of cyclophosphamide prodrug: structure-activity relationships of cyclophosphamide piperaziniums

Synthesis and antiviral activity of bisquaternary salts of 3,12-bis(3'-haloacyl)-3,12-diaza-6,9-diazoniadispiro

Synthesis and antiviral activity of spirobromine and its analog

Binding of a N,Nbisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families

Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins

Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus

DSTP-27 prevents entry of human cytomegalovirus

Antiulcer action of furoxanopyrimidine derivatives

Specific Antiviral Activity of Pyrimidinedispirotripiperazinium Alone and in Combination with Acyclovir on a Herpes-Simplex-Virus Infection Model

In vivo activity of pyrimidine-dispirotripiperaziniumin in the male guinea pig model of genital herpes

Novoselova, inventors; LLC "NEARMEDIC PLUS", assignee. Pyrimidyl-di(diazaspiro-alkanes) with antiviral activity

A dumbbell-shaped small molecule that promotes cell adhesion and growth

Small-moleculeinduced clustering of heparan sulfate promotes cell adhesion

Small Molecule Tools for

Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds

Per aspera ad astra: application of Simplex QSAR approach in antiviral research

Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research

Precompetitive preclinical ADME/Tox data: set it free on the web to facilitate computational model building and assist drug development

Ekins Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets

Open Source Bayesian Models. 2. Mining a "Big Dataset" To Create and Validate Models with ChEMBL

Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery

Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction

Multiple Machine Learning Comparisons of HIV Cell-based and Reverse Transcriptase Data Sets

We kindly acknowledge NIH NINDS: 1R01NS102164-01 and NIGMS R44GM122196-02A1. Dr. Alex Clark is kindly acknowledged for assistance with Assay Central ® .

• Dispirotripiperazines are positively charged spiro compounds first developed as anticancer drugs• In the following studies, it was found that the compounds also exhibit good antiviral activity• This review summarizes studies on the synthesis, antiviral evaluation and SAR of dispirotripiperazines and future directions in this area J o u r n a l P r e -p r o o f

X☐The authors declare that they have no known competing financialinterestsor personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: